Clinical Trials Sponsored by Nuvance Health
Total 50205 results
-
Nuvance HealthRecruitingPancreatic NeoplasmsUnited States
-
Nuvance HealthRecruitingPancreatic Neoplasms | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Stage IV | Pancreatic Cancer Stage IIIUnited States
-
Nuvance HealthYale UniversityRecruitingPancreatic Neoplasms | Pancreatic CancerUnited States
-
Nuvance HealthCompleted
-
Nuance HearingUnknownAttention Deficit Hyperactivity Disorder
-
Aquestive TherapeuticsCovance; Inventiv HealthWithdrawn
-
Revance Therapeutics, Inc.Syneos HealthCompletedCervical DystoniaUnited States, Spain, Germany, France, Czechia, Poland, United Kingdom, Canada, Austria
-
Aquestive TherapeuticsSyneos Health; CovanceCompletedEpilepsyUnited States
-
Aquestive TherapeuticsSyneos Health; CovanceCompleted
-
Revance Therapeutics, Inc.Syneos HealthCompletedCervical DystoniaUnited States, Spain, Germany, Austria, Poland, France, Canada, Czechia, United Kingdom
-
Aquestive TherapeuticsCovance; inVentiv Health ClinicalTerminatedAmyotrophic Lateral SclerosisUnited States
-
Aquestive TherapeuticsCovance; inVentiv Health ClinicalCompleted
-
CelgeneCovanceCompletedHealthyUnited States
-
AffibodyCovanceCompletedPsoriasis | Healthy SubjectsUnited Kingdom
-
EnteromeCovanceActive, not recruitingGlioblastoma, AdultUnited States, Spain, France, Germany
-
ShireCovance; PRA Health Sciences; PharmaNetCompletedMucopolysaccharidosis II | Hunter Syndrome | MPS IIBrazil, Poland, Taiwan
-
Nuance Pharma (shanghai) Co., LtdCompleted
-
Nuance Pharma (shanghai) Co., LtdCompletedChronic Obstructive Pulmonary DiseaseChina
-
Nuance Pharma (shanghai) Co., LtdCompleted
-
Iovance Biotherapeutics, Inc.RecruitingMelanoma | Metastatic Melanoma | Unresectable MelanomaUnited States, Spain, Australia, Netherlands, Sweden
-
Iovance Biotherapeutics, Inc.RecruitingMetastatic Melanoma | Unresectable Melanoma | Stage IV Non-small Cell Lung Cancer | Stage III Non-small Cell Lung CancerUnited States
-
GE HealthcareCovanceRecruitingMyocardial Ischemia | Coronary Artery DiseaseFrance, Greece, Italy, United Kingdom
-
Iovance Biotherapeutics, Inc.RecruitingCervical CarcinomaUnited States, Spain, United Kingdom, Germany, France, Italy, Netherlands, Switzerland
-
KBP BiosciencesCovanceCompletedHealthy | Drug Drug InteractionUnited States
-
KBP BiosciencesCovanceCompletedHealthyUnited States
-
KBP BiosciencesCovanceCompletedHealthy | Moderate Hepatic ImpairmentUnited States
-
Revance Therapeutics, Inc.CompletedPlantar FasciitisUnited States
-
CTI BioPharmaCovanceCompleted
-
Anji PharmaCovanceCompletedFunctional ConstipationChina, United States
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesUnited States, Canada
-
Algenis SpACovanceCompleted
-
Revance Therapeutics, Inc.Completed
-
Revance Therapeutics, Inc.CompletedSkin AgingUnited States
-
Revance Therapeutics, Inc.CompletedFacial Wrinkles | Lateral Canthal Lines | Crow's FeetUnited States
-
VIVUS LLCCovanceCompleted
-
Wellmarker BioCovanceRecruitingHead and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Cholangiocarcinoma | Advanced Solid Tumor | Metastatic Solid TumorKorea, Republic of, Australia
-
Iovance Biotherapeutics, Inc.RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
HiberCell, Inc.CovanceTerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Clear Cell Renal Cell Carcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Colo-rectal Cancer | Transitional Cell Carcinoma of the Bladder | Other Solid TumorsUnited States
-
Iovance Biotherapeutics, Inc.CompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Revance Therapeutics, Inc.CompletedPlantar FasciitisUnited States
-
CTI BioPharmaCovanceCompleted
-
Iovance Biotherapeutics, Inc.Active, not recruitingMetastatic MelanomaUnited States, Spain, Germany, United Kingdom, France, Hungary, Italy, Switzerland
-
Revance Therapeutics, Inc.CompletedFrown LinesUnited States, Canada
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States, Canada
-
Revance Therapeutics, Inc.Active, not recruiting
-
Revance Therapeutics, Inc.CompletedFacial Wrinkles | Lateral Canthal Lines | Crow's FeetUnited States
-
Revance Therapeutics, Inc.CompletedLateral Canthal LinesUnited States
-
Revance Therapeutics, Inc.CompletedTorticollis (Spasmodic)United States
-
Iovance Biotherapeutics, Inc.WithdrawnNon Small Cell Lung CancerUnited States